Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-26

FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for citalopram submitted by Cipla USA Inc., indicating approval of a supplemental marketing authorization for this gener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)